Semaglutide
Muzana ramakore rapfuura, iyo hypoglycemic drug market yakachinja.Sechigadzirwa chakagadzirwa muzana ramakore idzva, GLP-1 analogs dzave nyeredzi dzinopenya zvakanyanya mumunda wehypoglycemic nemabhenefiti eakanakisa hypoglycemic maitiro uye yakanaka yekurasikirwa uremu maitiro.Pakati pavo, kurasikirwa nehuremu kwave imwe yakakura inogona kushandiswa musika weGLP-1 mishonga.Parizvino, maitiro emakwikwi evatambi vakuru vanonanga GLP-1 receptor agonist kumba nekune dzimwe nyika zvishoma nezvishoma "zvinopisa".Tichamirira toona kuti ndiani achatungamira nekubata musika.
Semaglutide injection, rudzi rutsva rwehurefu-hurefu-glucose-1 (GLP-1) receptor agonist, ine insulin production uye Basa rekudzivisa kuvharwa kwepancreatic hyperglycemia, mishonga yakafanana inobatsirawo kuLutan peptide, ductal. peptide, nezvimwewo.
Muna Zvita 2017, iyo US Chikafu neDrug Administration (FDA) yakabvumidza kunyorwa kweSmeglugan peptide jekiseni kune yekubatsira kudzora kudya uye kurovedza muviri kuvandudza kudzora shuga yeropa yevarwere vane Type 2 chirwere cheshuga.Pamusoro pezvo, Novo neNord vakagadzirawo mushonga wemukanwa werudzi Rybelsus weSmeglugin, uye wakatanga kutenderwa neFDA munaGunyana 2019. Uyu zvakare ndiwo mushonga wekutanga kubvumidzwa pasi rose weGLP-1.chirwere cheshuga.Muchidimbu, Smeglugin mushonga wehypoglycemic, asi nekuti zvinodhaka zvakaita seSmeglugin peptide zvinogona kudzora dumbu risina chinhu uye kudzvanyirira kudya, zvinoderedza huremu.
Tichifunga izvi, muna Chikumi 2021, FDA yakabvumidza zviri pamutemo huremu hwehuremu hwekufutisa kana vakuru vakafuta.Vanhu vanoshandiswa ndivo: varwere vari nyore vane BMI ≥30 kg / m2;uye BMI> 27 kg/m2 uye kubatanidza kanenge kamwe kufutisa complication, senge hypertension, Type 2 chirwere cheshuga, kana abnormal blood lipids.Yakanga iri zvakare kubvumidzwa uku kuti kufananidzira kwakavigwa kwaSmeglugin mumugwagwa we "kurasikirwa kwemashiripiti mushonga".
Muna Kubvumbi 2021, Smegugan yakabvumidzwa muChina kudzora shuga yeropa kune varwere vane Type 2 chirwere cheshuga (T2DM).Kunyangwe chiratidzo chekurasikirwa nehuremu chisingatenderwe muChina, kudiwa kwehuremu hwepamba hakugone kuitwa muChina.Uye zvakare, iyo huru dingindira re "kuonda nekuonda", muhafu yechipiri ya2022, Smeglugin peptide "haina kutendera" mumunda wekuonda., Pane imwe nguva pane akawanda e-commerce mapuratifomu, yakagadzirisa bhoom mukutenga, uye yakambova yakakwira-mutengo "kunze kwestock mambo", izvo zvakakonzera zvakananga kumatambudziko ekugadzirwa kwevagadziri uye kupa.Nuo naNord's Chikunguru gore rapfuura vakati Kutangazve kwekupihwa kwezvinodhaka kuchamisa kupihwa kwemisika-yechipatara.
Kuzivikanwa kweSmegugu peptide kwakasimbiswa zvakare kubva kuNuo uye Nord's data data.Zvinoenderana nemhedzisiro ye2022 yazvino yakaziviswa naNuo naNord, mari yegore reNuo neNord's GLP-1 bhizinesi yaive 83.371 bhiriyoni Dan Ying Crown (yakaenzana ne81.6 bhiriyoni yuan), kuwedzera kwe56% gore-pa-gore.Pakati pavo, kutengesa kwaSmeglugin kwaive 59.75 bhiriyoni Dan Ying Crown (yakaenzana ne58.5 bhiriyoni yuan), kuwedzera kwe77% gore-pa-gore.Kuita kwekutengesa kweGLP-1 zvigadzirwa mumunda wemhando yechipiri chirwere cheshuga muChina kwakawedzera ne102% muDan Ying Krone.
Ehe, kuputika kweSmeglugin mumunda wekuremerwa uremu kwakabatana zvakanyanya nemhedzisiro yayo yakakosha."Inguva yekudya, kunwa uye kunwa, kutora mapaundi mashanu ehuremu, kurasikirwa mapaundi makumi matatu muna Ndira" zvichingodaro.Mukuwedzera, "kurara pasi" inogona kuva yakaonda, iyo yakakwezva maziso asingaverengeki kuSmegtu peptides, yaimbozivikanwa se "kurasikirwa kwemashiripiti mushonga".Nekudaro, vamwe varapi vakataura kuti Simei Gulu peptide ine zvinopfuura 2/3 zvekutengesa mudzimba muChina kuti udzike uremu, kwete chirwere cheshuga.Kune rumwe rutivi Mukutaura kweSmeglugan peptide semushonga wemishonga, kune njodzi dzakavanzika mukuchengetedzwa kwemishonga yepamusoro.
Zvakakosha kucherechedza kuti mhedziso dzekutsvaga dzemumba dzemishonga yakadai dzinobva kuvarwere vakakura vakafutisa.Kune vanhu vane huremu hushoma kana huremu hwemazuva ese (BM <27kg/m2), mabhenefiti uye njodzi dzinogona kuitika hazvisati zvazivikanwa.Mukuwedzera, kuwedzera kune maitiro e hypoglycemia ayo ari hypogenal zvinodhaka anowanikwa mumishonga ye hypoglycemic, maitiro emimba akakurumbira, uye chiitiko chekunyunyuta, kuvimbiswa, kurutsa uye manyoka kunosvika 82.8%.7%.Chinhu chakanyanya kukosha ndechekuti Smeglugin haina kubvumidzwa kune uremu zviratidzo muChina.Dambudziko remigero yemishonga uye kushandiswa kwezvinodhaka kwevanhu vakadai kwakakodzera kutariswa.
Nguva yekutumira: Aug-23-2023
.png)
